Insider · CIK 0001840006
Neil Harris Cohen
Files at CMMB (Chemomab Therapeutics Ltd.). First filing Sep 1, 2026, latest Sep 1, 2026.
Neil Harris Cohen files SEC Form 4 as director at CMMB (Chemomab Therapeutics Ltd.). Since Sep 1, 2026, Neil Harris Cohen has reported 0 open-market buys worth $0 and 1 open-market sell worth $6,516, the latest filed on Sep 1, 2026.
A track record needs three past buys with six months of prices behind them; Neil Harris Cohen has 0, so none is measured yet.
The newest scored trade: sold $6,516 of CMMB on Aug 27, 2026, filed Sep 1, 2026, scored 15 (weak). In the last 12 months: 0 buys worth $0 and 1 sell worth $6,516.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
CMMB: Chemomab Therapeutics Ltd.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 15Weak | CMMBsell Chemomab Therapeutics Ltd. | $6,516 2,304 shares | -7% | - |
Transactions
Every row this insider has filed, 9 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 27, 2026 | CMMB Chemomab Therapeutics Ltd. | SOpen-market sale American Depositary Shares | -1,304 | $2.85 | $3,716 | 34,000 | 42 d ago |
| Aug 28, 2026 | CMMB Chemomab Therapeutics Ltd. | SOpen-market sale American Depositary Shares | -1,000 | $2.80 | $2,800 | 33,000 | 42 d ago |
| Jul 16, 2020 | CMMB Chemomab Therapeutics Ltd. | AGrant or award Stock option (right to buy American Depositary Shares)derivative | +172 | $0.00 | $0 | 172 | 42 d ago |
| Apr 19, 2021 | CMMB Chemomab Therapeutics Ltd. | AGrant or award Stock option (right to buy American Depositary Shares)derivative | +2,971 | $0.00 | $0 | 3,143 | 42 d ago |
| Mar 7, 2022 | CMMB Chemomab Therapeutics Ltd. | AGrant or award Stock option (right to buy American Depositary Shares)derivative | +1,705 | $0.00 | $0 | 4,848 | 42 d ago |
| Mar 21, 2023 | CMMB Chemomab Therapeutics Ltd. | AGrant or award Stock option (right to buy American Depositary Shares)derivative | +1,714 | $0.00 | $0 | 6,562 | 42 d ago |
| Mar 18, 2024 | CMMB Chemomab Therapeutics Ltd. | AGrant or award Stock option (right to buy American Depositary Shares)derivative | +2,520 | $0.00 | $0 | 9,082 | 42 d ago |
| Mar 16, 2025 | CMMB Chemomab Therapeutics Ltd. | AGrant or award Stock option (right to buy American Depositary Shares)derivative | +3,821 | $0.00 | $0 | 12,903 | 42 d ago |
| Mar 16, 2026 | CMMB Chemomab Therapeutics Ltd. | AGrant or award Stock option (right to buy American Depositary Shares)derivative | +5,172 | $0.00 | $0 | 18,075 | 42 d ago |
Questions about Neil Harris Cohen
Answered from the filings on this page, as of the latest one.
Is Neil Harris Cohen buying or selling?
In the last 12 months Neil Harris Cohen reported 0 open-market buys worth $0 and 1 open-market sell worth $6,516 on SEC Form 4; the latest was sold $6,516 of CMMB on Aug 27, 2026. Grants, option exercises and tax withholding are not counted.
How did Neil Harris Cohen's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Neil Harris Cohen has 0.
Where does Neil Harris Cohen file Form 4?
Neil Harris Cohen has filed Form 4 at CMMB (Chemomab Therapeutics Ltd.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.